Healthcare -
Biotechnology - NASDAQ - US
$ 36.2
-0.958 %
$ 10.3 B
Market Cap
23.35
P/E
EXEL - COMMON STOCK REPURCHASED
Common Stock Repurchased EXEL - Exelixis, Inc.
-550 M
LAST VALUE
-275.14%
2 YEAR CAGR
-135.65%
5 YEAR CAGR
0.00%
10 YEAR CAGR